128 related articles for article (PubMed ID: 14670346)
1. Susceptibility of Mycobacterium tuberculosis to isoniazid and its derivative, 1-isonicotinyl-2-nonanoyl hydrazine: investigation at cellular level.
Mohamad S; Ibrahim P; Sadikun A
Tuberculosis (Edinb); 2004; 84(1-2):56-62. PubMed ID: 14670346
[TBL] [Abstract][Full Text] [Related]
2. Effects of isoniazid on viability, cell morphologies and acid fastness properties of Mycobacterium avium NCTC 8559 during the growth cycle.
Mohamad S; Ibrahim P; Wahab HA
Chemotherapy; 2007; 53(4):263-6. PubMed ID: 17595540
[TBL] [Abstract][Full Text] [Related]
3. Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs.
Coban AY; Cihan CC; Bilgin K; Uzun M; Akgunes A; Cetinkaya E; Durupinar B
Int J Tuberc Lung Dis; 2006 Apr; 10(4):450-3. PubMed ID: 16602412
[TBL] [Abstract][Full Text] [Related]
4. Insights on the Mechanism of Action of INH-C
Vila-Viçosa D; Victor BL; Ramos J; Machado D; Viveiros M; Switala J; Loewen PC; Leitão R; Martins F; Machuqueiro M
Mol Pharm; 2017 Dec; 14(12):4597-4605. PubMed ID: 29091448
[TBL] [Abstract][Full Text] [Related]
5. Experimental in vitro efficacy study on the interaction of epiroprim plus isoniazid against Mycobacterium tuberculosis.
Dosso M; Ouattara L; Cherif AM; Bouzid SA; Haller L; Fernex M
Chemotherapy; 2001; 47(2):123-7. PubMed ID: 11173814
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method.
Robledo J; Mejia GI; Paniagua L; Martin A; Guzmán A
Int J Tuberc Lung Dis; 2008 Dec; 12(12):1482-4. PubMed ID: 19017461
[TBL] [Abstract][Full Text] [Related]
7. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
[TBL] [Abstract][Full Text] [Related]
8. [Defining of gene mutations and minimal inhibitory concentrations in isoniazid resistant Mycobacterium tuberculosis isolates].
Yıldırım E; Uzun M
Mikrobiyol Bul; 2017 Oct; 51(4):305-316. PubMed ID: 29153061
[TBL] [Abstract][Full Text] [Related]
9. High-dose isoniazid therapy for isoniazid-resistant murine Mycobacterium tuberculosis infection.
Cynamon MH; Zhang Y; Harpster T; Cheng S; DeStefano MS
Antimicrob Agents Chemother; 1999 Dec; 43(12):2922-4. PubMed ID: 10582883
[TBL] [Abstract][Full Text] [Related]
10. Susceptibilities of Mycobacterium tuberculosis to isoniazid and rifampin on blood agar.
Coban AY; Bilgin K; Uzun M; Tasdelen Fisgin N; Akgunes A; Cihan CC; Birinci A; Durupinar B
J Clin Microbiol; 2005 Apr; 43(4):1930-1. PubMed ID: 15815022
[TBL] [Abstract][Full Text] [Related]
11. [A study of INH 0.1 microgram/ml resistant M. tuberculosis strains assessed by BrothMIC MTB-1 method].
Yoshida H; Ano H; Ishida C; Tanigawa N; Kikui M; Takashima T; Tsuyuguchi I
Kekkaku; 2002 Jul; 77(7):533-5. PubMed ID: 12187818
[TBL] [Abstract][Full Text] [Related]
12. Combinatory activity of linezolid and levofloxacin with antituberculosis drugs in Mycobacterium tuberculosis.
Santos NCS; Scodro RBL; de Almeida AL; Baldin VP; Nakamura de Vasconcelos SS; Siqueira VLD; Caleffi-Ferracioli KR; Campanerut-Sá PAZ; Cardoso RF
Tuberculosis (Edinb); 2018 Jul; 111():41-44. PubMed ID: 30029913
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.
Hearn MJ; Cynamon MH
Drug Des Discov; 2003; 18(4):103-8. PubMed ID: 15553921
[TBL] [Abstract][Full Text] [Related]
14. Proteomic and morphological changes produced by subinhibitory concentration of isoniazid in Mycobacterium tuberculosis.
Campanerut-Sá PA; Ghiraldi-Lopes LD; Meneguello JE; Fiorini A; Evaristo GP; Siqueira VL; Scodro RB; Patussi EV; Donatti L; Souza EM; Cardoso RF
Future Microbiol; 2016 Sep; 11():1123-32. PubMed ID: 27545345
[TBL] [Abstract][Full Text] [Related]
15. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis.
Foongladda S; Roengsanthia D; Arjrattanakool W; Chuchottaworn C; Chaiprasert A; Franzblau SG
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1118-22. PubMed ID: 12546122
[TBL] [Abstract][Full Text] [Related]
16. Isoniazid induces its own resistance in nonreplicating Mycobacterium tuberculosis.
Siddiqi S; Takhar P; Baldeviano C; Glover W; Zhang Y
Antimicrob Agents Chemother; 2007 Jun; 51(6):2100-4. PubMed ID: 17438054
[TBL] [Abstract][Full Text] [Related]
17. A rapid method for determination of susceptibility of Mycobacterium tuberculosis to isoniazid, using acridinium-ester-labeled DNA probe.
Teng LJ; Chung PF; Liaw SJ; Luh KT; Ho SW
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1994 Aug; 27(3):103-12. PubMed ID: 9747340
[TBL] [Abstract][Full Text] [Related]
18. Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of
Narang A; Giri A; Gupta S; Garima K; Bose M; Varma-Basil M
Int J Mycobacteriol; 2017; 6(2):177-183. PubMed ID: 28559521
[TBL] [Abstract][Full Text] [Related]
19. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands.
van Soolingen D; de Haas PE; van Doorn HR; Kuijper E; Rinder H; Borgdorff MW
J Infect Dis; 2000 Dec; 182(6):1788-90. PubMed ID: 11069256
[TBL] [Abstract][Full Text] [Related]
20. In vitro antimycobacterial activity of 2-(((2-hydroxyphenyl)amino)methylene)-5,5-dimethylcyclohexane-1,3-dione: a new chemical entity against Mycobacterium tuberculosis.
Rather MA; Bhat ZS; Lone AM; Maqbool M; Amin S; Bhat BA; Ahmad Z
Int J Antimicrob Agents; 2018 Aug; 52(2):265-268. PubMed ID: 29510188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
